TrialBritish journal of haematology2026

Achieving clinically meaningful changes in haemoglobin levels in patients with non-transfusion-dependent β-thalassaemia treated with luspatercept: A post hoc analysis of the phase 2 BEYOND trial.

Khaled M Musallam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.